Michael Dybbs
Director/Board Member at NKARTA, INC.
Net worth: - $ as of 31/03/2024
Profile
Mike Dybbs is a Partner at Samsara BioCapital, where he invests across all stages of the life science sector from seed stage to public equities.
He currently serves on the board of a number of Samsara portfolio companies, including: Enara Bio, IONpath, Levo Therapeutics, Nkarta Therapeutics and Sutro (STRO).
Prior to Samsara, Mike was a Partner at New Leaf Venture Partners.
Mike has served on the boards of Versartis (VSAR), Dimension Therapeutics (DMTX), Advanced Cell Diagnostics (acquired by Bio-Techne) and Principia.
Before joining New Leaf, Mike was a Principal at the Boston Consulting Group, where he was a core member of their health care practice.
Mike received an A.B.
in biochemical sciences from Harvard and a PhD in molecular biology from UC Berkeley, where he was awarded a Howard Hughes Medical Institute fellowship.
His research was published in peer-reviewed journals, including Nature, Science, and Neuron.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SUTRO BIOPHARMA, INC.
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
NKARTA, INC.
-.--% | 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Michael Dybbs active positions
| Companies | Position | Start |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Director/Board Member | 25/07/2018 |
| NKARTA, INC. | Director/Board Member | 01/08/2019 |
Fluent BioSciences, Inc.
 Fluent BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018. | Director/Board Member | - |
Samsara BioCapital LP
 Samsara BioCapital LP Investment ManagersFinance Samsara Biocapital LP invests in companies located in the US. The fund targets companies operating in the fields of biotechnology and pharmaceuticals. It provides financing for early stage capital requirements. | Director/Board Member | - |
565 SPV I LP
 565 SPV I LP Investment ManagersFinance 565 SPV I LP provides investment services. The company is headquartered in Palo Alto, CA. | Director/Board Member | - |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 01/01/2017 |
IONpath, Inc.
 IONpath, Inc. Medical/Nursing ServicesHealth Services IONpath, Inc. transforms pathology with multiplexed ion beam imaging. The company was founded by Michael Angelo, Sean Bendall, Harris Fienberg and Gerry Noland and is headquartered in San Mateo, CA. | Director/Board Member | - |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Director/Board Member | - |
Former positions of Michael Dybbs
| Companies | Position | End |
|---|---|---|
| DIMENSION THERAPEUTICS INC | Director/Board Member | 07/11/2017 |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Michael Dybbs
| University of California, Berkeley | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| RAYZEBIO, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Finance |
Advanced Cell Diagnostics, Inc.
 Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA. | Health Technology |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
IONpath, Inc.
IONpath, Inc. Medical/Nursing ServicesHealth Services IONpath, Inc. transforms pathology with multiplexed ion beam imaging. The company was founded by Michael Angelo, Sean Bendall, Harris Fienberg and Gerry Noland and is headquartered in San Mateo, CA. | Health Services |
Samsara BioCapital LP
Samsara BioCapital LP Investment ManagersFinance Samsara Biocapital LP invests in companies located in the US. The fund targets companies operating in the fields of biotechnology and pharmaceuticals. It provides financing for early stage capital requirements. | Finance |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Finance |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Health Technology |
565 SPV I LP
565 SPV I LP Investment ManagersFinance 565 SPV I LP provides investment services. The company is headquartered in Palo Alto, CA. | Finance |
Fluent BioSciences, Inc.
Fluent BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018. | Commercial Services |
- Stock Market
- Insiders
- Michael Dybbs
